Life Sciences

Intelligence gathered, not guessed.

For nearly 40 years, Fletcher's Life Science Practice Area has been a valued collaborator and trusted partner to the world's most respected life science and healthcare organizations. Driven by primary intelligence, deep industry expertise, and comprehensive data analysis, our team is well positioned to deliver and translate the most useful, meaningful, and high-quality insights. Executed by a specialized and focused team of full-time professionals, all hold advanced educational backgrounds, experience, and credentials. We are known for our worldwide network of thought leaders and international capabilities.

Contact

Industry experts. Domain focused.

Fletcher's Life Sciences practice is built on 40 years of specialized depth — not generalist coverage. We know the science, the stakeholders, and the strategic pressures at every stage of the healthcare value chain.

Broad-Based Therapeutic Area Knowledge

Our experience spans the full spectrum of disease states and clinical categories, including:

Oncology · Rare Disease & Orphan Drugs · Immunology & Inflammation · Cardiovascular & Metabolic · Neurology & CNS · Infectious Disease · Respiratory · Hematology · Endocrinology & Diabetes · Dermatology · Ophthalmology · Women's Health · Gastroenterology · Musculoskeletal · Gene & Cell Therapy · Vaccines & Biologics

Global Healthcare Value Chain

We bring comprehensive intelligence experience across the entire commercial and clinical continuum:

Stage 01 — Early Pipeline & Drug Discovery SciOps, Medical Affairs, and early developmental phase intelligence — competitor pipeline mapping, candidate benchmarking, and emerging science tracking ahead of the clinic.

Stage 02 — New Product Planning Competitive landscape and strategic positioning research ahead of launch decisions — understanding what you'll be entering and where the real market opportunities lie.

Stage 03 — Market Warming & Launch Preparedness Commercial readiness intelligence — monitoring competitor pre-launch activity, field force expansion, congress signaling, and payer engagement in advance of your own launch.

Stage 04 — Market Access Strategy Payer dynamics, trade and distribution intelligence, PBM and specialty pharmacy strategies, Medicare/Medicaid positioning, 340B, and patient/hub support — we map how competitors navigate access.

Stage 05 — Product Strategy & Lifecycle Management Sustained competitive monitoring through full LCM — including early warning on generic and biosimilar entrants, patent cliff intelligence, and competitor repositioning strategies.

Stage 06 — Global Policy & Regulatory Affairs International primary research across global healthcare policy environments — affordable care, managed care dynamics, and regulatory affairs spanning EU, APAC, and North American markets.

Asset & Sector Coverage

We support assets and organizations across every segment of the life sciences ecosystem:

Pharmaceutical · Biotechnology · Medical Technology · Diagnostics · Drug Delivery Systems · Digital Health & Health Tech · GPOs & IDNs · Patient & Provider Services · Hospital & Healthcare Services

Core Services

Primary Intelligence-Driven Win/Loss

Win/Loss Analysis reveals why deals are won or lost — directly from buyers themselves. Fletcher conducts independent, third-party interviews to surface honest feedback sales teams rarely hear internally.

Use cases include:

Identifying true decision criteria and buying triggers
Understanding why competitors win — or lose — head-to-head
Diagnosing sales execution, messaging, or pricing gaps
Improving forecast accuracy and sales effectiveness

Strategy Workshops & Scenario Planning

Strategy Workshops and Scenario Planning are facilitated, intelligence-led working sessions that transform competitive data into decisive action — stress-testing your strategy against real market conditions before your competitors force the test themselves.

Deliverables include:

Primary research briefings delivered before and during the session
Competitor scenario modeling based on verified field intelligence
Strategic vulnerability identification and response planning
Prioritized action frameworks aligned to your competitive realities

Competitor Deep Dives

A comprehensive, executive-ready view of a specific competitor’s strategy, positioning, pricing, strengths, weaknesses, and future direction. These profiles draw on primary interviews and expert context, not just public filings or scraped data.

Competitor business model and go-to-market motion
Strategic priorities and roadmap signals
Pricing practices and sales tactics
Strengths, weaknesses, opportunities, and threats (SWOT)
Implications for your strategy and execution plan

Global Market Monitoring & Surveillance

Global Market Monitoring and Surveillance is a continuous, human-powered intelligence program that keeps your organization ahead of competitor moves, market shifts, and emerging threats — across geographies, in real time, before signals become headlines

Highlights Include:

Ongoing primary research tracking across key global markets
Competitor activity signals — hiring, partnerships, field expansion, and messaging shifts
Early warning on emerging entrants, pipeline developments, and regulatory changes
Periodic intelligence briefings calibrated to your decision cadence

Battlecards

Battlecards are tactical, sales-ready playbooks that empower revenue teams to win more deals. Fletcher’s battlecards are crafted from real buyer intelligence, competitive analysis, and sales-verifiable insights — not generic matrices.

Key sections include:

Competitor positioning vs. your offering
Top differentiators and weakness exploitation
Buyer objections and proven counter-talk tracks
Proof points and win themes validated by interviews

Competitive Landscape

Market Landscapes is a structured, primary research-driven view of the competitive field — who the real players are, how they're positioned, and where the genuine white space lies. Built from human intelligence, not scraped data.

Key sections include:

Competitor identification, segmentation, and tier mapping
Positioning and messaging differentiation across the field
Market share signals and segment ownership patterns
Emerging entrants and disruption risks sourced from primary interviews

Customized & Ad-hoc Research

Not every competitive question fits a standard framework. Fletcher's customized research practice delivers bespoke primary intelligence scoped precisely to your question — designed from scratch around your timeline, your market, and the decision you need to make.

Core Components:

Rapid-turnaround primary research scoped to a specific competitive question
Custom research design — methodology, source mix, and deliverable format built to order
One-time or episodic engagements with no long-term retainer required
Flexible output formats — briefings, memos, presentations, or raw intelligence packages

Global Trade Show Intelligence

Industry events are gold mines for real-time competitive signals — if you know how to harvest them. Fletcher’s Conference Coverage delivers strategic and tactical intelligence from major tradeshows, symposiums, and global gatherings, with expert summaries.

Highlights include:

Product reveals and strategic shifts
Competitive activity and go-to-market cues
Emerging partner and ecosystem developments
Early trend signals before they hit public feeds

Case Studies

EU and APAC Field Force Study

To adapt its OUS sales strategies and field forces, a global, integrated pharmaceutical client needed to gain insight into the size, structure, and tactics of its top three competitors across China, Japan, and major EU markets.

Our Solution: Fletcher orchestrated a massive, global primary research initiative conducting interviews with competitors in the native language. Field force sizes, structures, and differentiating tactics were identified, then verified.
Outcome: The client planned and executed a blockbuster drug launch around known competitor hiring events, data releases, and marketing activities. This supported strategic decisions which allowed for more streamlined commercial operations in these markets.

Our Life Science Leadership

Senior VP, Life Sciences

Tina Witte

Tina Witte is Senior Vice President of Fletcher’s Life Science Practice Area, bringing 14 years of competitive and market intelligence expertise. She has deep experience across mass market and specialty pharmaceuticals, as well as drug delivery, diagnostics, regulatory, and market access. Tina has supported innovative products and platforms from early clinical development through launch and life cycle management, informed by insights gained at global medical and scientific congresses.

Sr Director of Life Science Research

Michael Kavouksorian

With 16+ years leading life science CI research, Mike brings deep primary research expertise across pharma, medical devices, HIT, GPOs, IDNs, payers, and market access. He coordinates and conducts research and data analysis, has attended more than 30 medical and life science conferences, and regularly leads and supports client engagements. Prior to Fletcher, he served as Manager of Financial Analysis at Dartmouth-Hitchcock Medical Center and as a Technical Solutions Analyst at Allscripts. Mike holds an MBA and a B.S. in Biomedical Technologies, both from the University of Vermont.

Get in Touch

info@fletchercsi.com